Phil Skolnick Opiant Pharmaceuticals, Inc. (OPNT) insider trading activity
Phil Skolnick is Chief Scientific Officer of OPIANT PHARMACEUTICALS, INC.. Currently has a direct ownership of 0 shares of OPNT, which is worth approximately $0. The most recent transaction as insider was on Mar 02, 2023, when has been sold 23,548 shares (Common Stock) at a price of $20.0 per share, resulting in proceeds of $470,960. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
0
0%
3M change
0%
12M change
Total Value Held
$0
Phil Skolnick Transaction History
PS
Phil Skolnick
Chief Scientific Officer
Santa Monica, CA